Clinicopathological characteristic and clinical handling of the patients with 2 cm or less gastric GISTs by unknown
a SpringerOpen Journal
Kataoka et al. SpringerPlus 2013, 2:469
http://www.springerplus.com/content/2/1/469RESEARCH Open AccessClinicopathological characteristic and clinical
handling of the patients with 2 cm or less
gastric GISTs
Mikinori Kataoka1*, Takashi Kawai2, Hidekazu Ikemiyagi1, Takashi Fujii1, Mari Fukuzawa3, Masakatsu Fukuzawa2,
Keisuke Kubota4, Masashi Yoshida4, Shinji Suzuki1 and Masaki Kitajima4Abstract
Background: We previously reported that safety and efficacy of mucosal cutting biopsy for diagnosing included
2 cm or less gastric GISTs. However, there have been no reports stating the clinicopathological characteristic and
clinical handling of the patients with 2 cm or less gastric GISTs. The aim of our study is to investigate the
clinicopathological characteristic and clinical handling of the patients with 2 cm or less gastric GISTs.
Methods: The 19 patients diagnosed with GIST by mucosal cutting biopsy were divided into 2 groups: Group I;
subjects were GISTs with 2 cm or less, Group II; subjects were GISTs >2 cm. We compared the 2 groups in terms of
mean age, tumor size, tumor site, histopathological risk grade. In cases that underwent surgery with a diagnosis of
GIST, we compared the pre- and postoperative histopathological diagnosis, and the histopathlogical risk grade
within each group.
Results: The mean age and tumor size were significantly higher in Group I than in Group II. Meanwhile, there were
no significant differences between the 2 groups, sex ratio, tumor site. All lesions were at histopathological risk
grade at very low risk and low risk respectively. In 17 patients with GIST who underwent surgery, the
histopathological diagnoses, immunostaining were in agreement with those from the mucosal cutting biopsy
specimens in all cases, but mitotic count of one patient was not in agreement in group II.
Conclusions: The 2 cm or less gastric GISTs diagnosed with histpathlogical very low risk can be considered
acceptable to follow-up.
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Gastrointestinal stromal tumors(GISTs) are the most
common submucosal tumors(SMTs) in the gastrointes-
tinal(GI) tract. The majority of GISTs are located in the
stomach, followed by the small intestine (20%-30%),
large intestine (5%), and esophagus (1%) (Fletcher et al.
2002a; Kitamura et al. 2003). GISTs show a wide variety
of clinical behavior, from benign to frankly malignant,
and outcome in individual patients remains difficult to
predict (Grotz & Donohue 2011). The Japanese GIST* Correspondence: mikinori@iuhw.ac.jp
1Department of Gastroenterology and Hepatology, International University Of
Health and Welfare Mita Hospital, 1-4-3 Mita, Minatoku, Tokyo 108-8329,
Japan
Full list of author information is available at the end of the article
© 2013 Kataoka et al.; licensee Springer. This is
Attribution License (http://creativecommons.or
in any medium, provided the original work is pTherapeutic Guidelines (GIST 2008) published in March
2008 state that important parameters of malignancy and
prognosis are thought to be growing tumor size, surface
morphological change, histopathological mitotic and cellu-
larity proliferative index. And surgical excision is indicated
if a histopathological diagnosis of GIST is made. However,
as with other SMTs, establishing a histologic diagnosis has
been considered extremely difficult. So as it stands now, the
patients with 2 cm or less gastric SMTs have been followed
up. We previously reported that safety and efficacy of mu-
cosal cutting biopsy for diagnosing included 2 cm or less
gastric GISTs (Kataoka et al. 2013).
The aim of our study is to investigate the clinicopatho-
logical characteristic and clinical handling of the patients
with 2 cm or less gastric GISTs.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 2 Patient characteristics of the 2 groups
Group I Group II
(n=11) (n=8)
Mean age (years) 57.3±13.8(37–75)* 68.9±8.4(57–85)
Sex ratio 7:4 7:1
Mean tumor size (mm) 17.4±3.2(10–20)* 28.7±5.1(25–40)
Tumor size L5 M2 U4 L0 M3 U5
Histological risk grade+ very low risk (11/11;100%) low risk (8/8;100%)
Values are presented as means ± standard deviation (SD).
Group I, patients with GISTs smaller tahn 2 cm; Group II, patients with GISTs>2 cm.
*p<0.05 compared with Group II.
+: Fletch’s criteria.
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Of a total of 29 patients without symptom diagnosed with
submucosal tumors emerged from the muscular layer by
endoscopic ultrasound (EUS) who underwent mucosal cut-
ting biopsy between September 2008 and December 2011
(Table 1), we diagnosed 19 patients (14 men and 5 women)
histopathologically as GIST. The 19 patients were di-
vided into 2 groups: Group I; subjects were GISTs with
2 cm or less, Group II; subjects were GISTs with >2 cm.
We compared the 2 groups in terms of mean age, tumor
size, tumor site (lower third: L; middle third: M; upper
third: U), and histopathological risk grade according toTable 1 The characteristics of the 29 patients with mucosal cutting biopsy
Endoscopic finding









1 M 37 L 20 GIST Homogeneous + − −
2 M 66 U 40 GIST Homogeneous + − −
3 M 61 U 30 GIST Homogeneous + − −
4 M 27 M 18 Heterotropic pancreas Homogeneous + − −
5 M 75 M 15 GIST Homogeneous + − −
6 M 58 U 20 GIST Homogeneous + − −
7 F 51 M 8 Leiomyoma Homogeneous + − −
8 F 85 M 30 GIST Homogeneous + − −
9 M 36 U 30 Heterotropic pancreas Homogeneous + − −
10 M 50 L 20 Leiomyoma Homogeneous + − −
11 M 72 U 25 GIST Homogeneous + − −
12 F 74 L 15 GIST Homogeneous + − −
13 M 50 U 15 GIST Homogeneous + − −
14 F 68 U 12 Leiomyoma Homogeneous + − −
15 F 68 U 19 GIST Homogeneous + − −
16 M 46 L 10 GIST Homogeneous + − −
17 F 49 U 20 GIST Homogeneous + − −
18 M 57 L 20 GIST Homogeneous + − −
19 F 46 M 30 Heterotropic pancreas Homogeneous + − −
20 M 57 M 30 GIST Homogeneous + − −
21 F 75 M 20 GIST Homogeneous + − −
22 F 64 U 20 Leiomyoma Homogeneous + − −
23 M 47 U 30 Leiomyoma Homogeneous + − −
24 F 54 L 20 Leiomyoma Homogeneous + − −
25 F 33 M 18 Leiomyoma Homogeneous + − −
26 M 73 U 25 GIST Homogeneous + − −
27 M 68 U 25 GIST Homogeneous + − −
28 M 42 L 18 GIST Homogeneous + − −
29 M 69 M 25 GIST Homogeneous + − −
EUS: endoscopic ultrasonagraphy.
α-SMA: α-smooth muscle actin.
L: lower third; M: middle third; U: upper third.
Table 3 Comparison of findings from mucosal cutting biopsy specimens and surgically resected specimens
Group I Case CD34 c-kit α-SMA Desmin s-100 Ki-67 Nuclear fission
1 Biopsy + + − − − 1% −
Resected specimen + + − − − 1% −
2 Biopsy + + − − − <10% −
Resected specimen + + − − − 1% 2
3 Biopsy + + − − − 1% −
Resected specimen + + − − − 1% <5
4 Biopsy + + − − − 1% −
Resected specimen + + − − − <1% −
5 Biopsy + + − − − 2% −
Resected specimen + + − − − 1% −
6 Biopsy + + − − − 3% −
Resected specimen + + − − − 3% −
7 Biopsy + + − − − <10% <5
Resected specimen + + − − − <10% <5
8 Biopsy + + − − − <10% −
Resected specimen + + − − − 5% −
9 Biopsy + + − − − <10% <5
Resected specimen + + − − − <10% <5
10 Biopsy + + − − − <10% −
Resected specimen + + − − − <10% −
Group II Case CD34 c-kit α-SMA Desmin s-100 Ki-67 nuclear fission
1 Biopsy + + − − − <10% −
Resected specimen + + − − − <3% <3
2 Biopsy + + − − − <10% <5
Resected specimen + + − − − 3% 4
3 Biopsy + + − − − 3% −
Resected specimen + + − − − 3% 8
4 Biopsy + + − − − <1% −
Resected specimen + + − − − <5% −
5 Biopsy + + − − − 3% −
Resected specimen + + − − − 3% −
6 Biopsy + + − − − <10% −
α-SMA: Resected specimen + + − − − <5% <3
α-smooth muscle actin 7 Biopsy + + − − − <10% −
Resected specimen + + − − − 3% −
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cellularity proliferative index. In cases that proceeded
to surgical resection with a diagnosis of GIST, we com-
pared the histopathological diagnoses from the muco-
sal cutting biopsy specimens and surgically resected
specimens within each group. Specimens were evalu-
ated using hematoxylin-eosin (HE) staining, as well as
staining for c-kit, CD34, α-SMA, S-100 protein, the cel-
lular proliferation antigen Ki-67, and mitotic counts
(per 50 high power fields).Statistical analysis was performed using the Fisher
exact test. A p-value of less than 0.05 was considered to
represent a statistically significant difference.
In this study, the method of histologic diagnosis for
gastric GISTs was approved by the Institutional Review
Board of Tokyo Medical University.
Results
Table 2 shows the characteristics of the patients in both
groups. The mean age was significantly higher in Group
Figure 1 Mucosal cutting biopsy. a,b) A 10-mm SMT on the greater curvature of the antrum c) Mucosal opening was made by mucosal
cutting d) Wound closure with clips.
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was also significantly higher in Group I than in Group II
(p < 0.05). Meanwhile, there were no significant differ-
ences in sex ratio, tumor site. However, in tumor site,
GISTs >2 cm were not on L site but on M and U sites.
The mitotic count of 11 GIST lesions in Group I and 8
of GIST lesions in Group II were all fewer than 5 per 50
HPF and all lesions were at histopathological risk grade
at very low risk (11/11, 100%) and low risk (8/8, 100%)
respectively, according to Fletch’s criteria
Of the 19 patients given a diagnosis of GIST, one patient
from each group refused surgical treatment owing to
advanced age and the remaining 17 patients underwent
surgical resection of their tumor. The histopathological,
immunostaining and mitotic count findings from the
surgically resected specimens were in agreement with
those from the mucosal cutting biopsy specimens in all
11 cases in Group I. On the other hand in Group II,
histopathological and immunostaining findings were
also in agreement, while mitotic count of one patient
was not in agreement. Therefore, the histopathlogical
risk grade of one case changed to moderate risk after
surgically resected specimen (Table 3).
All surgical cases and follow-up cases were confirmed the
healing of wound by surgical specimens and endoscopy.And there were no cases that had rapid growth in
follow-up cases.
Case 1
Case 1 was a 46-year-old man. EGD revealed an SMT ap-
proximately 10 mm in diameter on the greater curvature of
the antrum, which was smooth-sided and covered with
normal mucosa (Figure 1). The lesion was tense, hard and
immobile. We performed an endoscopic mucosal cutting
biopsy (Figure 1). The histopathological findings revealed
spindle cell tumor, with no mitotic figures. On the basis
of positive immunostaining for c-kit and CD34 (Figure 2),
a diagnosis of GIST was made. Furthermore, immuno-
staining of 3% for Ki-67 led to an assessment of a very
low histological degree of malignancy. We then performed
surgical resection in accordance with the GIST Therapeutic
Guidelines.
Discussion
Previously, GISTs were the most common submucosal
tumors with potential malignancy in the upper gastro-
intestinal (GI) tract, no matter if their size is small or
large, and it was difficult to predict their properties. There-
fore, surgical excision is indicated if a histopathological
diagnosis of GIST is made (GIST 2008). But the handling
Figure 2 Histopathological findings. a) Spindle cell tumor b,c) Positive immunostaining for c-kit and CD34 d) <3% staining for Ki-67 antigen, a
cellular proliferation marker.
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in Japan. In the actual clinical site, the 2 cm or less gastric
GISTs were resected in accordance with Japanese GIST
Therapeutic Guidelines.
On the other hand, Suzuki et al (2010) reported that
two of 16 cases in 2 cm or less GISTs increased during
followed-up and recommended that it should be followed-
up carefully. Also Nishida (2009) recommended a followed-
up for 2 cm or less GISTs without ulceration and border
irregularity. The recent rapid advances in endoscopic
intervention therapy provide a potential method for en
bloc resection of small Gastric SMTs. The modality of
endoscopic treatment includes endoscopic band ligation
(Liu-Ye et al. 2012; Sun et al. 2007), endpscopic submucosal
dissection (ESD) (Lee et al. 2006; Filippo et al. 2012). The
main defect of band ligation is that sloughed specimens are
not available for pathological confirmation. Nevertheless,
benign condition is comprised in SMTs like leopmyoma
and heterotopicc pancreas, the problem is that perforation
occurred during the ESD. Furthermore, successful complete
resection of ESD is not 100%. In 2010, Bai et al (2010)
reported that submucosal dissection technology for small
GISTs < 2 cm in stomach is feasible with a 28% perforation
rate, obviously higher than an overall 4% perforation in
ESD for early gastric cancer. Also, full-thickness resectionwas reported treatment of SMTs. Zhou et al (2011)
reported the complete resection rate was 100% in 26
patients with a SMT and there was no bleeding, periton-
itis, and abdominal abscess. However, such procedures de-
scribed previously cannot be accepted for a very benign
condition in Japan.
We compared the two divided groups of GISTs with
2 cm or less and GISTs with >2 cm. The mean age was
significantly higher in Group I than in Group II (p < 0.05).
Therefore, GISTs were anticipated that the size increased
as time passes. In tumor site, there was no GISTs >2 cm
on the L site. Then, the GISTs on the M and U site were
considered to have a chance of increasing. The histopatho-
logical and immunostaining findings from the surgically
resected specimens were in agreement with those from the
mucosal cutting biopsy specimens in all cases in Group I.
In addition, all cases were in agreement because of the mi-
totic count. Therefore histological risk grade were also in
agreement in all cases of Group I. These results indicate
that a follow-up of 2 cm or less GISTs on the L site can also
be considered acceptable. On the other hand, single case
was not in agreement with the mitotic count between the
mucosal cutting biopsy specimens and the surgically
resected specimens in Group II. En bloc resection was
very important for accurate histopathlogical diagnosis
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consider that the gastric GISTs >2 cm and 2 cm or less
gastric GISTs located on the M,U site were candidate
for surgical treatment.
In conclusion, if 2 cm or less gastric SMTs located on
the L site with a diagnosis of histpathlogical very low risk
GIST, we consider that a follow-up of them can also be
considered acceptable. On the other hand, traditionally,
we consider that the gastric GISTs >2 cm and 2 cm or less
gastric GISTs located on the M,U site were candidate for
surgical treatment. This study demonstrated that the clini-
copathological characteristic and clinical handling of the
patients with 2 cm or less small gastric GISTs.
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